RXRX Recursion Pharmaceuticals
- 8.840
- +0.050+0.57%
- 8.880
- +0.040+0.45%
Recursion Pharmaceuticals News
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gibson Christopher
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Marriott Tina
Recursion Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Khan Najat
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | ARS: Annual Report to Security Holders
Recursion Pharmaceuticals | DEFA14A: Others
Recursion Pharmaceuticals | DEF 14A: Definitive information statements
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Secora Michael
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 144/A: Others
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Recursion Pharmaceuticals | 8-K: Current report
Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Gibson Christopher
Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144
Analysis
Price Target
No Data
